In order to examine angiogenic effect of CD45+ BMCs in vivo, myocardial infarction surgery was performed followed by injection of PBS, CD45− BMCs (5×104) or CD45+ BMCs (5×104), respectively. This evidence concerns the gene PTPRC and myocardial infarction.